ESTRO Brachytherapy for Prostate Cancer 2018

HDR BOOST

• Optimal means of dose escalation for intermediate/high risk patients • Dose escalation results in better PSA RFS

• Acute toxicity equivalent or less than external beam • Late toxicity equivalent to external beam…but ?SABR